- Home
- RDCM vs FENC Comparison
RDCM vs FENC Comparison
Compare RDCM & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- FENC
- Stock Information
- Founded
- RDCM 1985
- FENC 1996
- Country
- RDCM Israel
- FENC United States
- Employees
- RDCM 307
- FENC N/A
- Industry
- RDCM Computer peripheral equipment
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDCM Technology
- FENC Health Care
- Exchange
- RDCM Nasdaq
- FENC Nasdaq
- Market Cap
- RDCM 210.6M
- FENC 222.9M
- IPO Year
- RDCM 1997
- FENC 2001
- Fundamental
- Price
- RDCM $13.72
- FENC $8.36
- Analyst Decision
- RDCM Strong Buy
- FENC Strong Buy
- Analyst Count
- RDCM 2
- FENC 2
- Target Price
- RDCM $16.00
- FENC $13.00
- AVG Volume (30 Days)
- RDCM 67.1K
- FENC 77.6K
- Earning Date
- RDCM 08-06-2025
- FENC 08-12-2025
- Dividend Yield
- RDCM N/A
- FENC N/A
- EPS Growth
- RDCM 111.69
- FENC N/A
- EPS
- RDCM 0.53
- FENC N/A
- Revenue
- RDCM $63,477,000.00
- FENC $30,912,000.00
- Revenue This Year
- RDCM $18.09
- FENC $0.85
- Revenue Next Year
- RDCM $11.46
- FENC $55.16
- P/E Ratio
- RDCM $25.69
- FENC N/A
- Revenue Growth
- RDCM 18.21
- FENC N/A
- 52 Week Low
- RDCM $9.08
- FENC $3.96
- 52 Week High
- RDCM $15.98
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- RDCM 60.98
- FENC 59.42
- Support Level
- RDCM $12.90
- FENC $7.94
- Resistance Level
- RDCM $13.79
- FENC $8.51
- Average True Range (ATR)
- RDCM 0.70
- FENC 0.44
- MACD
- RDCM 0.10
- FENC -0.03
- Stochastic Oscillator
- RDCM 87.42
- FENC 71.86
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.